NervGen Pharma receives approval from safety review committee to proceed to second cohort in multiple ascending dose portion of Phase 1 clinical trial of NVG-291! Read full press release at link below. https://t.co/8Wwwfgr6Oi #clinicaltrials#drugdevelopment#biotech#research
๐๐๐๐๐๐๐ ๐ ๐๐ ๐ ๐๐๐๐
Want to purchase tickets? โฌ๏ธ
https://t.co/PvGQEMHHDn
Can't make it but would like to donate towards their research?ย โฌ๏ธ
https://t.co/EiPRqI0DzF
Would you please consider donating?
@elonmusk@OleMissFBโ In memory of Chucky Mullins๐ค
@dallasmavs โ Can share with Shawn Bradley?
@UAB_FBโ In honor of Tim Alexander
@HarvardFootballโ In honor of Ben Abercrombie
@SInow@brianburnsed Want to purchase tickets? โฌ๏ธ
https://t.co/PvGQEMHHDn
Can't make it but would like to donate towards their research?ย โฌ๏ธ
https://t.co/EiPRqI0DzF